Re-Entry MTC for Offenders with MICA Disorders

患有 MICA 疾病的罪犯重新进入 MTC

基本信息

项目摘要

DESCRIPTION (provided by applicant): Offenders having both mental illness and chemical abuse (MICA) disorders are a population of interest, in part because their special needs place exceptional demands on criminal justice and treatment systems, as well as on individuals and families. The proposed study examines the crucial point of transition from prison to the community, where continued treatment for offenders is generally considered necessary to sustain gains made by prison treatment efforts, and to achieve successful outcomes. On their release from prison, male offenders with MICA disorders who elect to participate in this study (N = 332), will be placed in either the experimental condition, (E) Re-entry Modified Therapeutic Community (Re-entry MTC) or the control condition, (C) Parole Supervision and Case Management currently provided, using a randomized block assignment procedure. The research employs a prospective, longitudinal, repeated measures assessment with five data collection points: baseline (Time 1, or T1) corresponding to entry into the Community Corrections facility and at 3 (T2), 6 (T3), 12 (T4), and 18 (T5) months post-baseline. The major study hypothesis is that the E condition (compared to the C condition) will produce significantly greater improvement in the presenting problems of the study participants, as measured by substance use, mental health symptoms, and criminal activities. This project will advance scientific knowledge through a controlled study of the effectiveness of the MTC model, with demonstrated success in community settings, as a re-entry strategy for offenders with MICA disorders, thereby expanding the range of treatment models available to such clients in the community. In addition, the study will examine the degree to which prior prison treatment moderates the effectiveness of the Re-entry MTC, or the extent to which positive outcomes are independent of the type of treatment received during the prior incarceration. This distinction will inform program planning by establishing the value of MTC treatment in prison plus MTC during re-entry versus MTC re-entry treatment alone. Finally, the study tests a specific hypothesis about the degree to which the effectiveness of Re-entry MTC treatment is mediated by client progress during reentry, which will increase our understanding of the relationship between progress in treatment and post-treatment outcomes for offenders with MICA disorders.
描述(由申请人提供): 同时患有精神疾病和化学滥用(MICA)障碍的罪犯是一个令人感兴趣的人群,部分原因是他们的特殊需求对刑事司法和治疗系统以及个人和家庭提出了特殊要求。拟议的研究探讨了从监狱到社区过渡的关键点,在社区中,对罪犯的持续治疗被普遍认为是维持监狱治疗努力取得的成果并取得成功结果所必需的。选择参加本研究的患有 MICA 疾病的男性罪犯 (N = 332) 出狱后,将被置于实验条件、(E) 再入改良治疗社区(再入 MTC)或控制条件,(C) 目前提供的假释监督和案件管理,使用随机分组分配程序。该研究采用前瞻性、纵向、重复测量评估,有五个数据收集点:对应于进入社区惩教设施的基线(时间 1 或 T1)以及 3 (T2)、6 (T3)、12 (T4)、以及基线后 18 (T5) 个月。主要研究假设是,E 条件(与 C 条件相比)将显着改善研究参与者目前存在的问题,通过物质使用、心理健康症状和犯罪活动来衡量。 该项目将通过对 MTC 模型有效性的对照研究来推进科学知识,并在社区环境中取得了成功,作为患有 MICA 疾病的罪犯的重新进入策略,从而扩大了此类客户可用的治疗模型的范围。社区。此外,该研究还将考察先前的监狱待遇对重返 MTC 有效性的影响程度,或者积极结果在多大程度上独立于先前监禁期间接受的治疗类型。这种区别将通过确定监狱中的 MTC 治疗加上重返监狱期间的 MTC 与单独的 MTC 再入治疗的价值来为规划规划提供信息。最后,该研究测试了一个具体假设,即重返 MTC 治疗的有效性在多大程度上是由客户在重返期间的进展所介导的,这将增加我们对 MICA 罪犯治疗进展与治疗后结果之间关系的理解失调。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Randomized trial of a reentry modified therapeutic community for offenders with co-occurring disorders: crime outcomes.
针对患有并发疾病的罪犯的再入改良治疗社区的随机试验:犯罪结果。
  • DOI:
  • 发表时间:
    2012-04
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Sacks, Stanley;Chaple, Michael;Sacks, JoAnn Y;McKendrick, Karen;Cleland, Charles M
  • 通讯作者:
    Cleland, Charles M
Responding to the challenge of co-occurring disorders: suggestions for future research.
应对并发疾病的挑战:对未来研究的建议。
  • DOI:
  • 发表时间:
    2008-01
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Sacks, Stanley;Chandler, Redonna;Gonzales, Junius
  • 通讯作者:
    Gonzales, Junius
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stanley Sacks其他文献

Stanley Sacks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stanley Sacks', 18)}}的其他基金

Region 2 ATTC: NJ, NY, PR & the U.S. VI
区域 2 ATTC:新泽西州、纽约州、波多黎各
  • 批准号:
    8549023
  • 财政年份:
    2012
  • 资助金额:
    $ 60.34万
  • 项目类别:
Region 2 ATTC: NJ, NY, PR & the U.S. VI
区域 2 ATTC:新泽西州、纽约州、波多黎各
  • 批准号:
    8541254
  • 财政年份:
    2012
  • 资助金额:
    $ 60.34万
  • 项目类别:
Computerized Psychosocial Treatment for Offenders with Substance Use Disorders
对患有药物滥用障碍的罪犯进行计算机化心理社会治疗
  • 批准号:
    7855764
  • 财政年份:
    2009
  • 资助金额:
    $ 60.34万
  • 项目类别:
Computerized Psychosocial Treatment for Offenders with Substance Use Disorders
对患有药物滥用障碍的罪犯进行计算机化心理社会治疗
  • 批准号:
    7941747
  • 财政年份:
    2009
  • 资助金额:
    $ 60.34万
  • 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
  • 批准号:
    7106372
  • 财政年份:
    2005
  • 资助金额:
    $ 60.34万
  • 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
  • 批准号:
    7257106
  • 财政年份:
    2005
  • 资助金额:
    $ 60.34万
  • 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
  • 批准号:
    6959665
  • 财政年份:
    2005
  • 资助金额:
    $ 60.34万
  • 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
  • 批准号:
    7474754
  • 财政年份:
    2005
  • 资助金额:
    $ 60.34万
  • 项目类别:
NDRI Rocky Mountain Research Center for CJDATS 2
NDRI 落基山研究中心 CJDATS 2
  • 批准号:
    7681427
  • 财政年份:
    2002
  • 资助金额:
    $ 60.34万
  • 项目类别:
NDRI Rocky Mountain Research Center for CJDATS 2
NDRI 落基山研究中心 CJDATS 2
  • 批准号:
    7789440
  • 财政年份:
    2002
  • 资助金额:
    $ 60.34万
  • 项目类别:

相似国自然基金

基于lncRNA NONHSAT042241/hnRNP D/β-catenin轴探讨雷公藤衍生物(LLDT-8)对类风湿关节炎滑膜成纤维细胞功能影响及机制研究
  • 批准号:
    82304988
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
针刺手法和参数对针刺效应启动的影响及其机制
  • 批准号:
    82305416
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
二仙汤影响肾上腺皮质-髓质激素分泌及调控下丘脑温度感受器以缓解“天癸竭”潮热的研究
  • 批准号:
    82374307
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
固定翼海空跨域航行器出水稳定性与流体动力载荷影响机制
  • 批准号:
    52371327
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
经济制裁对跨国企业海外研发网络建构的影响:基于被制裁企业的视角
  • 批准号:
    72302155
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
  • 批准号:
    10706874
  • 财政年份:
    2023
  • 资助金额:
    $ 60.34万
  • 项目类别:
Exposure and Response Prevention to Improve Functioning in Veterans with Obsessive Compulsive Disorder
暴露和反应预防以改善患有强迫症的退伍军人的功能
  • 批准号:
    10426818
  • 财政年份:
    2022
  • 资助金额:
    $ 60.34万
  • 项目类别:
Exposure and Response Prevention to Improve Functioning in Veterans with Obsessive Compulsive Disorder
暴露和反应预防以改善患有强迫症的退伍军人的功能
  • 批准号:
    10623218
  • 财政年份:
    2022
  • 资助金额:
    $ 60.34万
  • 项目类别:
HYBRID TYPE 1 EFFECTIVENESS-IMPLEMENTATION TRIAL FOR PRIMARY CARE DEPRESSION SCREENING AND REFERRAL TO A REMOTE DIGITAL MENTAL HEALTH CLINIC
初级保健抑郁症筛查和转诊至远程数字心理健康诊所的混合 1 型有效性实施试验
  • 批准号:
    10375031
  • 财政年份:
    2022
  • 资助金额:
    $ 60.34万
  • 项目类别:
A Hybrid Effectiveness-Implementation Multisite Trial of a Dialectical Behavior Therapy Skills Group for Veterans at High-Risk for Suicide Attempt
针对自杀未遂高风险退伍军人的辩证行为治疗技能组的混合有效性实施多地点试验
  • 批准号:
    10541795
  • 财政年份:
    2021
  • 资助金额:
    $ 60.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了